PET study of the neuroprotective effect of TRA-418, an antiplatelet agent, in a monkey model of stroke

Journal of Nuclear Medicine

Volumn 46, Issue 11, 2005, Pages 1931-1936

  Umemura, Kazuo ^a   Tsukada, Hideo ^b   Kakiuchi, Takeharu ^b   Yamada, Naohiro ^c   Matsuura, Hirotoshi ^c  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CENTRAL RESEARCH LABORATORY   (Japan)

^c TORAY INDUSTRIES INC   (Japan)

Author keywords

Antiplatelet agency; Monkey stroke model; PET

Indexed keywords

ANTITHROMBOCYTIC AGENT; TRA 418; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; OXAZINE DERIVATIVE; TRA418;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; LOW DRUG DOSE; MALE; MONKEY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME; ANIMAL; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; HUMAN; MACACA; SCINTISCANNING;

ANIMALS; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MACACA FASCICULARIS; MALE; NEUROPROTECTIVE AGENTS; OXAZINES; PLATELET AGGREGATION INHIBITORS; POSITRON-EMISSION TOMOGRAPHY; TREATMENT OUTCOME;

EID: 32044462554     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Grau AJ, Ruf A, Vogt A, et al. Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost. 1998;80:298-301.
2. van Kooten F, Ciabattoni G, Patrono C, Dippel DW, Koudstaal PJ. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke. 1997;28:1557-1563.
3. Investigators TAIIS. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. The abciximab in ischemic stroke investigators. Stroke. 2000;31:601-609.
4. Cheung RTF, Ho DSW. Fatal hemorrhagic transformation of acute cerebral infarction after the use of abciximab. Stroke. 2000;31:2518-2519.
5. Miyamoto M, Yamada N, Ikezawa S, et al. Effects of TRA-418, a novel TP-receptor antagonist and IP-receptor agonist, on human platelet activation and aggregation. Br J Pharmacol. 2003;140:889-894.
6. 2 receptor agonistic activities: its antiplatelet effects in human and animal platelets. J Thromb Haemost. 2003;1:1813-1819.
7. Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33: 2123-2136.
8. Takamatsu H, Tsukada H, Kakiuchi T, Nishiyama S, Noda A, Umemura K. Detection of reperfusion injury using positron emission tomography in a monkey model of cerebral ischemia. J Nucl Med. 2000;41:1409-1416.
9. Takamatsu H, Tsukada H, Noda A, et al. FK506 attenuates early neuronal death in a monkey model of stroke. J Nucl Med. 2001;42:1833-1840.
10. Watanabe M, Okada H, Shimizu K, et al. A high resolution animal PET scanner using compact PS-PMT detectors. IEEE Trans Nucl Sci. 1997;44:1277-1282.
11. 15O and positron emission tomography: theory, procedure and normal values. J Comput Assist Tomogr. 1980;4:727-736.
12. Young AR, Sette G, Touzani O. Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion: an investigation in anesthetized baboons with positron emission tomography. J Cereb Blood Flow Metab. 1996;16:1176-1188.
13. Sette G, Baron JC, Mazoyer B, Levasseur M, Pappata S, Crouzel C. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease: positron emission tomography. Brain. 1989;112:931-951.
14. 2: a reliable indicator of platelet hyperfunction in patients with ischemic stroke. Acta Neurol Scand. 1991;83:99-102.
15. CAPRIE steering committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
16. International stroke trial collaborative group. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-1581.
17. 2 analog, TEI-7165, on ischemic neuronal damage in gerbils. Brain Res. 1997;769: 321-328.
18. Stier CT, Chander PN, Belmonte A, Inamdar RS, Mistry M. Beneficial action of beraprost sodium, a prostacyclin analog, in stroke-prone rats. J Cardiovasc Pharmacol. 1997;30:285-293.
19. Sobesky J, Thiel A, Ghaemi M, et al. Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion. J Cereb Blood Flow Metab. 2005;1-7.
20. Kito G, Nishimura A, Susumu T, et al. Experimental thromboembolic stroke in cynomolgus monkey. J Neurosci Method. 2001;105:45-53.